विधियों की तुलना करें
चुनी हुई विधियों की आमने-सामने समीक्षा करें; भिन्नता वाली पंक्तियाँ रेखांकित हैं।
| AGHDA× | AddiQoL: एड्रेनल अपर्याप्तता जीवन गुणवत्ता पैमाना× | |
|---|---|---|
| क्षेत्र | अंतःस्रावी विज्ञान | अंतःस्रावी विज्ञान |
| परिवार | Process / pipeline | Process / pipeline |
| उद्भव वर्ष≠ | 2000 | 2012 |
| प्रवर्तक≠ | Anthony Hunt, Garry Werther, Peter Wrightson | Adriana Evers, Jeanieke Tiemensma |
| प्रकार | Patient self-report questionnaire | Patient self-report questionnaire |
| मौलिक स्रोत≠ | Hunt, A. E., Werther, G. A., & Wrightson, P. (2000). The utility of AGHDA in identifying GH-deficient adults. Clin Endocrinol (Oxf), 52(3), 341-346. link ↗ | Evers, A. C., & Tiemensma, J. (2012). AddiQoL: A disease-specific quality of life scale for patients with primary adrenal insufficiency. J Clin Endocrinol Metab, 97(10), 3501-3508. link ↗ |
| उपनाम≠ | AGHDA-25 | Addison Quality of Life, AI-QoL |
| संबंधित | 3 | 3 |
| सारांश≠ | The AGHDA is a 25-item disease-specific quality of life questionnaire designed to assess the burden of adult growth hormone (GH) deficiency. Developed by Hunt, Werther, and colleagues in 2000, it evaluates symptoms and functional impairments directly related to GH deficiency, including fatigue, reduced muscle strength, weight gain, and psychological difficulties. The instrument is widely used in endocrinology practice and clinical trials to quantify the impact of GH replacement therapy. | AddiQoL is a disease-specific quality of life questionnaire developed to assess the burden of primary and secondary adrenal insufficiency, encompassing physical, emotional, and social domains relevant to patients on glucocorticoid and mineralocorticoid replacement therapy. Developed by Evers and Tiemensma in 2012, it is the first formally validated instrument specifically designed for adrenal insufficiency populations. |
| ScholarGateडेटासेट ↗ |
|
|